Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
https://www.wcvb.com/article/sarepta-therapeutics-duchenne-muscular-dystrophy-treatment-cost/44314518
0
0
Cambridge-based Sarepta Therapeutics to charge $3.2M for new Duchenne muscular dystrophy treatment - WCVB Boston
6/23/23 at 1:10pm
Organization
WCVB Boston
40 words
0
Comments
FDA approval of the new treatment from a Cambridge-based company marks the first gene therapy to treat a deadly form of muscular dystrophy.
Pharmaceuticals & Biotech
Business & Industrial
Drugs & Medications
Health Conditions
Sarepta
Cambridge
Duchenne
FDA
Boston
WCVB
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...